Varex Imaging (NASDAQ:VREX) Stock Rating Lowered by Wall Street Zen

Key Points

• Wall Street Zen downgraded Varex Imaging from a "strong-buy" to a "buy"; analysts' ratings net out to a Moderate Buy consensus with a $16.17 average price target (1 Strong Buy, 2 Buy, 1 Hold, 1 Sell).
• Varex beat Q1 estimates with $0.19 EPS (vs. $0.14 expected) and $209.6M revenue (vs. $207.8M), and issued Q2 2026 guidance of $0.15–$0.25 EPS while analysts look for about $0.93 for the year.
• Director Jay K. Kunkel sold 4,510 shares (~$50,241) on March 20, reducing his holding by 16.13%; insiders collectively own 4.60% of the company.

Varex Imaging (NASDAQ:VREX - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a report released on Saturday.

A number of other research firms have also recently issued reports on VREX. B. Riley Financial reaffirmed a "buy" rating on shares of Varex Imaging in a research report on Thursday, February 12th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Varex Imaging in a research report on Friday, March 27th. Jefferies Financial Group reaffirmed a "hold" rating and issued a $14.50 price objective on shares of Varex Imaging in a research report on Monday, February 2nd. Finally, Zacks Research raised Varex Imaging from a "hold" rating to a "strong-buy" rating in a research report on Monday, April 13th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Varex Imaging currently has an average rating of "Moderate Buy" and a consensus price target of $16.17.

Varex Imaging Stock Performance

VREX opened at $12.53 on Friday. Varex Imaging has a 12-month low of $6.76 and a 12-month high of $14.56. The stock has a market cap of $525.01 million, a price-to-earnings ratio of -7.64 and a beta of 0.99. The business has a 50 day moving average of $11.79 and a 200-day moving average of $12.14. The company has a quick ratio of 1.87, a current ratio of 3.89 and a debt-to-equity ratio of 0.75.

Varex Imaging (NASDAQ:VREX - Get Free Report) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.05. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.The company had revenue of $209.60 million during the quarter, compared to analysts' expectations of $207.83 million. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. On average, equities research analysts expect that Varex Imaging will post 0.93 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Jay K. Kunkel sold 4,510 shares of Varex Imaging stock in a transaction that occurred on Friday, March 20th. The stock was sold at an average price of $11.14, for a total transaction of $50,241.40. Following the completion of the sale, the director directly owned 23,450 shares of the company's stock, valued at approximately $261,233. This trade represents a 16.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 4.60% of the company's stock.

Institutional Trading of Varex Imaging

Several hedge funds have recently added to or reduced their stakes in VREX. Franklin Resources Inc. grew its position in Varex Imaging by 2.2% during the 4th quarter. Franklin Resources Inc. now owns 57,720 shares of the company's stock worth $672,000 after acquiring an additional 1,261 shares during the last quarter. SG Americas Securities LLC grew its position in Varex Imaging by 4.4% during the 1st quarter. SG Americas Securities LLC now owns 30,202 shares of the company's stock worth $320,000 after acquiring an additional 1,272 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in Varex Imaging by 10.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company's stock worth $133,000 after acquiring an additional 1,442 shares during the last quarter. Deutsche Bank AG grew its position in Varex Imaging by 5.7% during the 4th quarter. Deutsche Bank AG now owns 27,459 shares of the company's stock worth $320,000 after acquiring an additional 1,477 shares during the last quarter. Finally, Comerica Bank grew its position in Varex Imaging by 9.3% during the 3rd quarter. Comerica Bank now owns 20,363 shares of the company's stock worth $253,000 after acquiring an additional 1,726 shares during the last quarter.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company's medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.